Biflavonoids of Dacrydium balansae with Potent Inhibitory Activity on Dengue 2 NS5 Polymerase

Abstract

In order to find new molecules for antiviral drug design, we screened 102 ethyl acetate extracts from New-Caledonian flora for antiviral activity against the dengue 2 virus RNA-dependant RNA polymerase (DV-NS5 RdRp). The leaf extract of Dacrydium balansae, which strongly inhibited the DV-NS5, was submitted to bioguided fractionation. Four biflavonoids (1–4), three sterols (5–7), and two stilbene derivatives (8–9) were identified and evaluated for their antiviral potential on the DV-NS5 RdRp. Biflavonoids appeared to be potent inhibitors of DV-NS5 RdRp with IC₅₀s between 0.26 and 3.12 µM. Inhibitory activity evaluations against the RNA polymerase from other Flaviviridae viruses allowed us to conclude that these compounds are specific inhibitors of the DV RNA polymerase. The strongest inhibitions were observed with hinokiflavone (4), but podocarpusflavone A (2) is the strongest noncytotoxic inhibitor of the DV-NS5 and it also displayed polymerase inhibitory activity in a DV replicon. A preliminary structure-activity relationship study (SARs) revealed the necessity of the biflavonoid skeleton, the influence of number and position of methoxylations, and the importance of a free rotation of the linkage between the two apigenin monomers of the biflavonoids. To the best of our knowledge, podocarpusflavone A (2) is the strongest noncytotoxic non-nucleotide molecule exhibiting a specific inhibitory activity against the RNA polymerase domain of DV-NS5 and thus is promising for chemotherapy development against dengue fever.

Key words

biflavonoids - Dacrydium balansae - Podocarpaceae - dengue virus - DV-NS5 RdRp

References

• 1 Ghosh D, Basu A. Present perspectives on flaviviral chemotherapy.  Drug Discov Today. 2008;  13 619-624
• 2 Knipe D. Field's virology, 5th edition. Philadelphia: Lippincott Williams & Wilkins; 2007: 1409-1439
• 3 Tomlinson S M, Watowich S J. Anthracene-based inhibitors of dengue virus NS2B–NS3 protease.  Antiviral Res. 2011;  89 127-135
• 4 Bollati M, Alvarez K, Assenberg R, Baronti C, Canard B, Cook S, Coutard B, Decroly E, de Lamballerie X, Gould E A, Grard G, Grimes J M, Hilgenfeld R, Jansson A M, Malet H, Mancini E J, Mastrangelo E, Mattevi A, Milani M, Moureau G, Neyts J, Owens R J, Ren J, Selisko B, Speroni S, Steuber H, Stuart D I, Unge T, Bolognesi M. Structure and functionality in flavivirus NS-proteins: perspectives for drug design.  Antiviral Res. 2010;  87 125-148
• 5 Selisko B, Dutartre H, Guillemot J C, Debarnot C, Benarroch D, Khromykh A, Desprès P, Egloff M P, Canard B. Comparative mechanistic studies of de novo RNA synthesis by flavivirus RNA-dependent RNA polymerases.  Virology. 2006;  351 145-158
• 6 Malet H, Massé N, Selisko B, Romette J L, Alvarez K, Guillemot J C, Tolou H, Yap T L, Vasudevan S, Lescar J, Canard B. The flavivirus polymerase as a target for drug discovery.  Antiviral Res. 2008;  80 23-35
• 7 Myers N, Mittermeier R A, Mittermeier C G, da Fonseca G A B, Ken J. Biodiversity hotspots for conservation priorities.  Nature. 2000;  403 853-858
• 8 Paeshuyse J, Letellier C, Froeyen M, Dutartre H, Vrancken R, Canard B, De Clercq E, Gueiffier A, Teulade J C, Herdewijn P, Puerstinger G, Koenen F, Kerkhofs P, Baraldi P G, Neyts J. A pyrazolotriazolopyrimidinamine inhibitor of bovine viral diarrhea virus replication that targets the viral RNA-dependent RNA polymerase.  Antiviral Res. 2009;  82 141-147
• 9 Massé N, Davidson A, Ferron F, Alvarez K, Jacobs M, Romette J L, Canard B, Guillemot J C. Dengue virus replicons: production of an interserotypic chimera and cell lines from different species, and establishment of a cell-based fluorescent assay to screen inhibitors, validated by the evaluation of ribavirin's activity.  Antiviral Res. 2010;  86 296-305
• 10 Della Greca M, Monaco P, Previtera L. Stigmasterols from Typha latifolia.  J Nat Prod. 1990;  53 1430-1435
• 11 Georges P, Sylvestre M, Ruegger H, Bourgeois P. Ketosteroids and hydroxyketosteroids, minor metabolites of sugarcane wax.  Steroids. 2006;  71 647-652
• 12 Markham K R, Sheppard C, Geiger H. ¹³C NMR studies of some naturally occuring amentoflavone, and hinokiflavone biflavonoids.  Phytochemistry. 1987;  26 3335-3337
• 13 McCarthy F O, Chopra J, Ford A, Hogan S A, Kerry J P, O'Brien N M, Ryan E, Maquire A R. Synthesis, isolation and characterisation of beta-sitosterol and beta-sitosterol oxide derivatives.  Org Biomol Chem. 2005;  3 3059-3065
• 14 Murias M, Handler N, Erker T, Pleban K, Ecker G, Saiko P, Szekeres T, Jäger W. Resveratrol analogues as selective cyclooxygenase-2 inhibitors: synthesis and structure-activity relationship.  Bioorg Med Chem. 2004;  12 5571-5578
• 15 Ryu Y B, Jeong H J, Kim J H, Kim Y M, Park J Y, Kim D, Naguyen T T H, Park S J, Chang J S, Park K H, Rho M C, Lee W S. Biflavonoids from Torreya nucifera displaying SARS-CoV 3 CL^pro inhibition.  Bioorg Med Chem. 2010;  18 7940-7947
• 16 Schneider Y, Chabert P, Stutzmann J, Coelho D, Fougerousse A, Gossé F, Launay J F, Brouillard R, Raul F. Resveratrol analog (Z)-3, 5, 4′-trimethoxystilbene is a potent anti-mitotic drug inhibiting tubulin polymerization.  Int J Cancer. 2003;  107 189-196
• 17 Berry K M, Perry N B, Weavers R T. Foliage sesquiterpenes of Dacrydium cupressinum identification, variation and biosynthesis.  Phytochemistry. 1985;  24 2893-2898
• 18 Quinn C J, Gadek P. Biflavones of Dacrydium sensu lato.  Phytochemistry. 1981;  20 677-681
• 19 Chong J, Poutaraud A, Hugueney P. Metabolism and roles of stilbenes in plants.  Plant Sci. 2009;  177 143-155
• 20 Koonin E. The phylogeny of RNA-dependent RNA polymerases of positive-strand RNA viruses.  J Gen Virol. 1991;  72 2197-2206
• 21 Havsteen B H. The biochemistry and medical significance of the flavonoids.  Pharmacol Ther. 2002;  96 67-202